PERKINELMER INC (PKI) Stock Fundamental Analysis

NYSE:PKI • US7140461093

115.24 USD
-1.06 (-0.91%)
At close: May 15, 2023
115.24 USD
0 (0%)
After Hours: 5/15/2023, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall PKI gets a fundamental rating of 5 out of 10. We evaluated PKI against 58 industry peers in the Life Sciences Tools & Services industry. While PKI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PKI had positive earnings in the past year.
  • PKI had a positive operating cash flow in the past year.
PKI Yearly Net Income VS EBIT VS OCF VS FCFPKI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 500M 1B

1.2 Ratios

  • PKI has a Return On Assets of 5.28%. This is in the better half of the industry: PKI outperforms 76.19% of its industry peers.
  • PKI's Return On Equity of 10.11% is fine compared to the rest of the industry. PKI outperforms 77.78% of its industry peers.
  • PKI's Return On Invested Capital of 6.49% is fine compared to the rest of the industry. PKI outperforms 73.02% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PKI is significantly above the industry average of 11.97%.
  • The last Return On Invested Capital (6.49%) for PKI is well below the 3 year average (52.37%), which needs to be investigated, but indicates that PKI had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROIC 6.49%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
PKI Yearly ROA, ROE, ROICPKI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 16.32%, PKI belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
  • PKI's Profit Margin has improved in the last couple of years.
  • The Operating Margin of PKI (23.43%) is better than 88.89% of its industry peers.
  • PKI's Operating Margin has improved in the last couple of years.
  • PKI has a better Gross Margin (58.39%) than 76.19% of its industry peers.
  • PKI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
PKI Yearly Profit, Operating, Gross MarginsPKI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PKI is creating value.
  • PKI has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, PKI has an improved debt to assets ratio.
PKI Yearly Shares OutstandingPKI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
PKI Yearly Total Debt VS Total AssetsPKI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

  • PKI has an Altman-Z score of 2.51. This is not the best score and indicates that PKI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PKI's Altman-Z score of 2.51 is in line compared to the rest of the industry. PKI outperforms 55.56% of its industry peers.
  • PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
  • The Debt to FCF ratio of PKI (7.40) is better than 77.78% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that PKI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.53, PKI is doing worse than 68.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Altman-Z 2.51
ROIC/WACC0.65
WACC10.02%
PKI Yearly LT Debt VS Equity VS FCFPKI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.3 Liquidity

  • PKI has a Current Ratio of 2.13. This indicates that PKI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.13, PKI is doing worse than 68.25% of the companies in the same industry.
  • A Quick Ratio of 1.87 indicates that PKI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.87, PKI is doing worse than 65.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.87
PKI Yearly Current Assets VS Current LiabilitesPKI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for PKI have decreased strongly by -30.47% in the last year.
  • PKI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.15% yearly.
  • Looking at the last year, PKI shows a decrease in Revenue. The Revenue has decreased by -3.37% in the last year.
  • The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%

3.2 Future

  • Based on estimates for the next years, PKI will show a small growth in Earnings Per Share. The EPS will grow by 6.04% on average per year.
  • Based on estimates for the next years, PKI will show a decrease in Revenue. The Revenue will decrease by -8.60% on average per year.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PKI Yearly Revenue VS EstimatesPKI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PKI Yearly EPS VS EstimatesPKI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.51, which indicates a correct valuation of PKI.
  • Based on the Price/Earnings ratio, PKI is valued cheaper than 96.83% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.98. PKI is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 22.11, the valuation of PKI can be described as rather expensive.
  • 77.78% of the companies in the same industry are more expensive than PKI, based on the Price/Forward Earnings ratio.
  • PKI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
PKI Price Earnings VS Forward Price EarningsPKI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PKI is valued cheaper than 93.65% of the companies in the same industry.
  • PKI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PKI is cheaper than 87.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.52
EV/EBITDA 12.35
PKI Per share dataPKI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • PKI has a very decent profitability rating, which may justify a higher PE ratio.
  • PKI's earnings are expected to decrease with -4.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PKI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PERKINELMER INC

NYSE:PKI (5/15/2023, 8:04:00 PM)

After market: 115.24 0 (0%)

115.24

-1.06 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-11
Earnings (Next)07-31
Inst Owners86.56%
Inst Owner Change-6.67%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
P/S 3.19
P/FCF 24.52
P/OCF 21.43
P/B 1.97
P/tB N/A
EV/EBITDA 12.35
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROCE N/A
ROIC 6.49%
ROICexc 6.74%
ROICexgc 35.96%
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0.99%
ROICexgc growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Debt/EBITDA 2.93
Cap/Depr 20.05%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 79.63%
Current Ratio 2.13
Quick Ratio 1.87
Altman-Z 2.51
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%

PERKINELMER INC / PKI FAQ

What is the ChartMill fundamental rating of PERKINELMER INC (PKI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PKI.


What is the valuation status of PERKINELMER INC (PKI) stock?

ChartMill assigns a valuation rating of 7 / 10 to PERKINELMER INC (PKI). This can be considered as Undervalued.


Can you provide the profitability details for PERKINELMER INC?

PERKINELMER INC (PKI) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for PKI stock?

The Earnings per Share (EPS) of PERKINELMER INC (PKI) is expected to decline by -34.36% in the next year.


Can you provide the dividend sustainability for PKI stock?

The dividend rating of PERKINELMER INC (PKI) is 0 / 10 and the dividend payout ratio is 4.74%.